Institute Report
Advancing Equitable and Timely Access to Personalized Oncology Therapies: Middle East and Africa
Summary Highlights from a Multi-Stakeholder Panel Discussion at the 13th Annual Emirates Oncology Conference in November 2025
Mar 12, 2026
Download

This summary provides highlights from a discussion at an in-person and virtual multi-stakeholder symposium at the 13th Annual Emirates Oncology Conference in Abu Dhabi, UAE, on November 14, 2025. The panel discussion, Advancing Equitable and Timely Access to Personalized Oncology Therapies: Middle East and Africa, covered the challenges and opportunities in accessing precision oncology therapies across various regions.

Participants represented Egypt, Saudi Arabia, South Africa, and the UAE. Building on the IQVIA Institute’s published report, Oncology Therapy Access in the Era of Personalized Medicine: Trends in regulatory and reimbursement for select countries in the Middle East and Africa, the aim of this session was to further the ongoing discussion about timely access to precision oncology therapies.

The panel was comprised of a broad range of stakeholders, including oncology clinicians, policy leaders, and ex-payers.

The symposium was organized by the IQVIA Institute for Human Data Science as a public service with funding from AbbVie and was intended to continue the timely conversation and propose a call to action for equitable patient access to precision oncology therapies.

Contact Us